Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Mary's Medicinals Products Now Available to Illinois Medical Cannabis Patients Through a Unique Partnership with GTI

Mary’s Medicinals
Posted on: 13 Sep 16

PR Newswire

DENVER and ROCK ISLAND, Ill., Sept. 13, 2016

DENVER and ROCK ISLAND, Ill., Sept. 13, 2016 /PRNewswire/ -- MM Technology Holdings, LLC, today announced that it has partnered with Green Thumb Industries, LLC (GTI) to produce and distribute its line of Mary's Medicinals transdermal cannabis products for patients across Illinois.

"Mary's has developed a line of unique products with unparalleled quality, accuracy and an exceptional reputation for effectiveness," said Ben Kovler, co-founder & managing partner, GTI. "We're excited to bring these products to patients across Illinois that have been seeking new, highly-targeted medical cannabis delivery options."

Mary's Medicinals has established itself as one of the most trusted and innovative producers of canna-based products in Colorado, and has since expanded into additional states on both coasts. Mary's was first to offer THCa and CBN products; discovered harvesting techniques for the isolation of CBC, and continues to develop cutting edge approaches for isolating, manufacturing and delivering medicinal cannabis.

"The potential of cannabinoid therapies as a treatment for many conditions is enormous. However, the traditional cannabis products on the market today don't appeal to all patients," said Nicole Smith, CEO of Mary's Medicinals. "With Mary's unique delivery and accurate dosing mechanisms, patients are finding relief that is more effective, more reliable and more targeted than anything else available. We're pleased to join forces with the highly-regarded and qualified team at GTI to help bring new forms of relief to the patients of Illinois."

Available in THC Indica, THC Sativa, THCa, CBN, CBD and CBD/THC, Mary's flagship patches are 2x2 squares, easy to use, and adhere simply to any part of the skin for up to 12 hours of all day (or night) relief. Mary's offers a line of patented high bioavailability transdermal gels and topical compounds that complement its patches. GTI will also distribute Mary's Nutritionals cannabinoid rich hemp products. Every batch of Mary's products is laboratory tested for quality, accuracy and consistency.

Mary's products are currently available in Illinois, Arizona, Vermont, Oregon, California, Washington and Colorado. To find the location nearest you, visit: Look for Mary's products in additional states later this year.

About GTI:
Green Thumb Industries, LLC (GTI) is dedicated to providing the patients of Illinois with the most effective and therapeutic medical cannabis products throughout the state.  GTI's team of experienced cannabis cultivation operators bring unmatched expertise and superior quality to patients in need. More information is available at:

About Mary's Medicinals:
Mary's Medicinals is a wellness company innovating at the intersection of engineering and horticulture. Mary's is focused on transforming how people view and utilize cannabis, developing products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care Mary's Medicinals and Mary's Nutritionals are affiliates of MM Technology Holdings, LLC.  More information is available at:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.

Supporting Resources:

Press Contact:
Graham Sorkin 

Logo -


To view the original version on PR Newswire, visit:

SOURCE Mary’s Medicinals

PR Newswire

Last updated on: 13/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.